Study identifier:D1692C00014
ClinicalTrials.gov identifier:NCT02200666
EudraCT identifier:N/A
CTIS identifier:N/A
Forxiga Tablets Specific Clinical Experience Investigation for long-term use
Type 2 Diabetes Mellitus
N/A
No
-
All
7793
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Feb 2020 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|